AXM Pharma, Inc. (AXMP)

AXM Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2017	FY 2005
Period Ending	Apr 28, 2025	Dec 31, 2017	Dec 31, 2005
Debt / Equity Ratio	0.63	0.61	-
Debt / EBITDA Ratio	-	1.70	-
Debt / FCF Ratio	-	1.98	-
Quick Ratio	0.14	0.14	0.12
Current Ratio	0.70	0.68	0.42
Return on Capital Employed (ROCE)	26.00%	30.60%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.